Instructions for Taufone (Taurine) Eye Drops 10 ml 4%
English product name
Taufone
Release form
eye drops 4%: 5 ml or 10 ml fl-droppers 1 or 2 pcs.
Description:
Eye drops in the form of transparent, colourless liquid.
1 ml
taurin 40 mg
Auxiliary substances: methylparahydroxybenzoate - 1 mg, hydroxide sodium solution 1M to pH 5.0-6.5, water d/i - up to 1 ml.
ATC codes
S01XA Other preparations for the treatment of eye diseases
Active substance
taurin
Pharmacotherapy group
Metabolic agent
Pharmacological effect Taurine:
Taurine is a natural product of the exchange of sulfur amino acids: cysteine, cysteamine, methionine. Taurine has osmoregulatory and membrane-protective properties, positively influences the phospholipid composition of cell membranes, normalizes the exchange of calcium and potassium ions in cells, and improves the conditions for nerve impulse.
It stimulates reparative and regenerative processes in cases of diseases of dystrophic character and/or diseases accompanied by a sharp disruption of the metabolism of the eye tissues.
Testimony Taurine:
Dystrophic diseases of retina, including hereditary tapetoretinal degeneration; Corneal dystrophy cataract (senile, diabetic, traumatic, radiotherapy); corneal injury (as a stimulant of reparative processes); primary open-angle glaucoma (combined with beta-adrenolocators for topical use in ophthalmology).
Method of use, course and dosage:
The dosage regimen depends on the indications and the drug form used.
Drug interaction Taurine
In patients with glaucoma, the simultaneous use of taurine with thymolol maleate indicates an increase in the hypotensive effect by increasing the outflow ease factor and reducing the production of aqueous humor.
Use in children
It is contraindicated under the age of 18 years (effectiveness and safety are not established).
- Nosology Taurine (ICD codes)
- H18.4
- Degeneration of the cornea
- H18.5
- Hereditary corneal dystrophy
- H25
- Cataract
- H26
- Other cataracts
- H35.0
- Background retinopathy and retinal vascular changes
- H35.4
- Peripheral retinal degeneration
- H35.5
- Hereditary retinal dystrophies
- H36.0
- Diabetic retinopathy
- H40.1
- Primary open-angle glaucoma
- S05
- Eye injury
